Home Teva offers to buy Mylan in $40.1B cash-and-stock deal
 

Keywords :   


Teva offers to buy Mylan in $40.1B cash-and-stock deal

2015-04-21 17:05:03| Biotech - Topix.net

Teva has offered to buy Mylan for about $40.1 billion in cash and stock in a deal that would create a powerhouse of generic drug development. If Teva manages to acquire Mylan under the offer announced Tuesday, it would help Teva secure a more dominant position as it would be taking Mylan off of a growing list of competitors.

Tags: buy offers deal teva

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Kim Madigan to chair 2025 FTA Fall Technical Conference
05.11PM responds to Sir Alan Bates after repeated requests
More »